These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27567537)

  • 1. The stress-inducible transcription factor ATF4 accumulates at specific rRNA-processing nucleolar regions after proteasome inhibition.
    Galimberti V; Kinor N; Shav-Tal Y; Biggiogera M; Brüning A
    Eur J Cell Biol; 2016 Oct; 95(10):389-400. PubMed ID: 27567537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive nucleolar and Cajal body responses to proteasome inhibition in sensory ganglion neurons.
    Palanca A; Casafont I; Berciano MT; Lafarga M
    Biochim Biophys Acta; 2014 Jun; 1842(6):848-59. PubMed ID: 24269586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis.
    Xian M; Cao H; Cao J; Shao X; Zhu D; Zhang N; Huang P; Li W; Yang B; Ying M; He Q
    Int J Cancer; 2017 Sep; 141(5):1029-1041. PubMed ID: 28524233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.
    Dong Z; Zhu C; Zhan Q; Jiang W
    Oncotarget; 2017 Feb; 8(8):13240-13252. PubMed ID: 28099941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib.
    Milani M; Rzymski T; Mellor HR; Pike L; Bottini A; Generali D; Harris AL
    Cancer Res; 2009 May; 69(10):4415-23. PubMed ID: 19417138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of Nrf2 and ATF4 in differential induction of CHOP by proteasome inhibition in thyroid cancer cells.
    Zong ZH; Du ZX; Li N; Li C; Zhang Q; Liu BQ; Guan Y; Wang HQ
    Biochim Biophys Acta; 2012 Aug; 1823(8):1395-404. PubMed ID: 22691366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib.
    Nakamura S; Miki H; Kido S; Nakano A; Hiasa M; Oda A; Amou H; Watanabe K; Harada T; Fujii S; Takeuchi K; Kagawa K; Ozaki S; Matsumoto T; Abe M
    Int J Hematol; 2013 Jul; 98(1):66-73. PubMed ID: 23708974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.
    Luo J; Xia Y; Yin Y; Luo J; Liu M; Zhang H; Zhang C; Zhao Y; Yang L; Kong L
    Theranostics; 2019; 9(21):6334-6353. PubMed ID: 31534554
    [No Abstract]   [Full Text] [Related]  

  • 9. Human NF-κB repressing factor acts as a stress-regulated switch for ribosomal RNA processing and nucleolar homeostasis surveillance.
    Coccia M; Rossi A; Riccio A; Trotta E; Santoro MG
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1045-1050. PubMed ID: 28096332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation.
    Brüning A; Rahmeh M; Friese K
    Mol Oncol; 2013 Dec; 7(6):1012-8. PubMed ID: 23916134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis.
    Lee DM; Kim IY; Seo MJ; Kwon MR; Choi KS
    Exp Mol Med; 2017 Aug; 49(8):e365. PubMed ID: 28798402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability.
    Latonen L; Moore HM; Bai B; Jäämaa S; Laiho M
    Oncogene; 2011 Feb; 30(7):790-805. PubMed ID: 20956947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosomal protein RPL41 induces rapid degradation of ATF4, a transcription factor critical for tumour cell survival in stress.
    Wang A; Xu S; Zhang X; He J; Yan D; Yang Z; Xiao S
    J Pathol; 2011 Oct; 225(2):285-92. PubMed ID: 21706477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy.
    Narita T; Ri M; Masaki A; Mori F; Ito A; Kusumoto S; Ishida T; Komatsu H; Iida S
    Blood Cancer J; 2015 Dec; 5(12):e373. PubMed ID: 26636288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PML nuclear bodies-associated protein TTRAP regulates ribosome biogenesis in nucleolar cavities upon proteasome inhibition.
    Vilotti S; Biagioli M; Foti R; Dal Ferro M; Lavina ZS; Collavin L; Del Sal G; Zucchelli S; Gustincich S
    Cell Death Differ; 2012 Mar; 19(3):488-500. PubMed ID: 21921940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of autophagy by ATF4 in response to severe hypoxia.
    Rzymski T; Milani M; Pike L; Buffa F; Mellor HR; Winchester L; Pires I; Hammond E; Ragoussis I; Harris AL
    Oncogene; 2010 Aug; 29(31):4424-35. PubMed ID: 20514020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapeutic effects of bortezomib and anacardic acid on multiple myeloma cells via activation of the endoplasmic reticulum stress response.
    Dong X; Liao Y; Liu N; Hua X; Cai J; Liu J; Huang H
    Mol Med Rep; 2016 Sep; 14(3):2679-84. PubMed ID: 27430733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 localizes to intranucleolar regions distinct from the ribosome production compartments.
    Krüger T; Scheer U
    J Cell Sci; 2010 Apr; 123(Pt 8):1203-8. PubMed ID: 20332106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ISRIB plus bortezomib triggers paraptosis in breast cancer cells via enhanced translation and subsequent proteotoxic stress.
    Lee DM; Seo MJ; Lee HJ; Jin HJ; Choi KS
    Biochem Biophys Res Commun; 2022 Mar; 596():56-62. PubMed ID: 35114585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct states of nucleolar stress induced by anticancer drugs.
    Potapova TA; Unruh JR; Conkright-Fincham J; Banks CAS; Florens L; Schneider DA; Gerton JL
    Elife; 2023 Dec; 12():. PubMed ID: 38099650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.